CARDIOVASCULAR JOURNAL OF AFRICA • Vol 24, No 5, June 2013
170
AFRICA
non-sudden and sudden cardiac death after acute myocardial infarc-
tion in the beta-blocking era.
J Am Coll Cardiol
2004;
43
: 757–763
(14998613).
2.
Savoye C, Equine O, Tricot O, Nugue O, Segrestin B, Sautière K,
et al
.
Left ventricular remodeling after anterior wall acute myocardial infarc-
tion in modern clinical practice (from the REmodelage VEntriculaire
[REVE] study group).
Am J Cardiol
2006;
98
: 1144–1149 (17056315).
3.
Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc
P,
et al
. Rapid measurement of B-type natriuretic peptide in the emer-
gency diagnosis of heart failure.
N Engl J Med
2002;
347
: 161–167
(12124404).
4.
Ahn MS, Yoo BS. Two problems with analyzing natriuretic Peptide
levels: obesity and acute myocardial infarction.
Korean Circ J
2010;
40
: 550–551 (21217930).
5.
Garcia-Alvarez A, Sitges M, Delgado V, Ortiz J, Vidal B, Poyatos S,
et al
. Relation of plasma brain natriuretic peptide levels on admission
for ST-elevation myocardial infarction to left ventricular end-diastolic
volume six months later measured by both echocardiography and cardi-
ac magnetic resonance.
Am J Cardiol
2009;
104
: 878–882 (19766750).
6.
Katayama T, Nakashima H, Yonekura T, Honda Y, Suzuki S, Yano K.
Clinical significance of acute-phase brain natriuretic peptide in acute
myocardial infarction treated with direct coronary angioplasty
. J
Cardiol
2003;
42
: 195–200 (14658407).
7.
Hirayama A, Kusuoka H, Yamamoto H, Sakata Y, Asakura M, Higuchi
Y,
et al
. Serial changes in plasma brain natriuretic peptide concentra-
tion at the infarct and non-infarct sites in patients with left ventricular
remodelling after myocardial infarction.
Heart
2005;
91
: 1573–1577
(15774610).
8.
Hirayama A, Kusuoka H, Yamamoto H, Sakata Y, Asakura M, Higuchi
Y,
et al
. Usefulness of plasma brain natriuretic peptide concentration
for predicting subsequent left ventricular remodeling after coronary
angioplasty in patients with acute myocardial infarction
. Am J Cardiol
2006;
98
: 453–457 (16893696).
9.
Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R,
Feigenbaum H,
et al
. Recommendations for quantitation of the left
ventricle by two-dimensional echocardiography. American Society
of Echocardiography Committee on Standards, Subcommittee on
Quantitation of Two-Dimensional Echocardiograms.
J Am Soc
Echocardiogr
1989;
2
: 358–367 (2698218).
10. Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quiñones MA.
Doppler tissue imaging: a noninvasive technique for evaluation of left
ventricular relaxation and estimation of filling pressures.
J Am Coll
Cardiol
1997;
30
: 1527–1533 (9362412).
11. Mega JL, Morrow DA, De Lemos JA, Sabatine MS, Murphy SA, Rifai
N,
et al
. B-type natriuretic peptide at presentation and prognosis in
patients with ST-segment elevation myocardial infarction: an ENTIRE-
TIMI-23 substudy.
J Am Coll Cardiol
2004;
44
: 335–339 (15261928).
12. Vorlat A, Claeys MJ, Bosmans JM, Van Hoof V, Vrints CJ. B-type
natriuretic peptide and assessment of jeopardised myocardium in acute
myocardial infarction.
Int J Cardiol
2007;
114
: 46–49 (16644042).
13. Richards AM, Nicholls MG, Yandle TG, Frampton C, Espiner EA,
Turner JG,
et al.
Plasma N-terminal pro-brain natriuretic peptide and
adrenomedullin: new neurohormonal predictors of left ventricular func-
tion and prognosis after myocardial infarction.
Circulation
1998;
97
:
1921–1929 (9609085).
14. Richards AM, Nicholls MG, Yandle TG, Ikram H, Espiner EA, Turner
JG,
et al
. Neuroendocrine prediction of left ventricular function and
heart failure after acute myocardial infarction. The Christchurch
Cardioendocrine Research Group.
Heart
1999;
81
: 114–120 (9922344).
15. Crilley JG, Farrer M. Left ventricular remodelling and brain natriu-
retic peptide after first myocardial infarction.
Heart
2001;
86
: 638–642
(11711456).
16. Bassan R, Potsch A, Maisel A, Tura B, Villacorta H, Nogueira MV,
et al
.
B-type natriuretic peptide: a novel early blood marker of acute myocar-
dial infarction in patients with chest pain and no ST-segment elevation.
Eur Heart J
2005;
26
: 234–240 (15618053).
17. Dengler TJ, Gleissner CA, Klingenberg R, Sack FU, Schnabel PA,
Katus HA. Biomarkers after heart transplantation: nongenomic.
Heart
Fail Clin
2007;
3
: 69–81 (17545010).
18. Menger MD, Vollmar B. Pathomechanisms of ischemia-reperfusion
injury as the basis for novel preventive strategies: is it time for the
introduction of pleiotropic compounds?
Transplant Proc
2007;
39
:
485–488 (17362764).
19. Jaffe R, Dick A, Strauss BH. Prevention and treatment of microvascular
obstruction related myocardial injury and coronary no-reflow follow-
ing percutaneous coronary intervention: a systematic approach.
JACC
Cardiovasc Interv
2010;
3
: 695–704 (20650430).
20. Bruder O, Jensen C, Jochims M, Farazandeh M, Barkhausen J,
Schlosser T,
et al.
Relation of B-type natriuretic peptide (BNP) and
infarct size as assessed by contrast-enhanced MRI.
Int J Cardiol
2010;
144
: 53–58 (19410308).
21. Roubille F, Samri A, Cornillet L, Sportouch-Dukhan C, Davy JM,
Raczka F,
et al
. Routinely-feasible multiple biomarkers score to predict
prognosis after revascularized STEMI.
Eur J Intern Med
2010;
21
:
131–136 (20206886).
22. Suzuki E, Hirata Y, Kohmoto O, Sugimoto T, Hayakawa H, Matsuoka
H,
et al
. Cellular mechanisms for synthesis and secretion of atrial
natriuretic peptide and brain natriuretic peptide in cultured rat atrial
cells.
Circ Res
1992;
71
: 1039–1048 (1394868).
23. Richards AM, Nicholls MG, Espiner EA, Lainchbury JG, Troughton
RW, Elliott J,
et al
. B-type natriuretic peptides and ejection fraction
for prognosis after myocardial infarction.
Circulation
2003;
107
:
2786–2792 (12771003).
24. Morita E, Yasue H, Yoshimura M, Ogawa H, Jougasaki M, Matsumura
T,
et al
. Increased plasma levels of brain natriuretic peptide in
patients with acute myocardial infarction.
Circulation
1993;
88
: 82–91
(8319360).
25. Hillis GS, Ujino K, Mulvagh SL, Hagen ME, Oh JK. Echocardiographic
indices of increased left ventricular filling pressure and dilation after
acute myocardial infarction.
J Am Soc Echocardiogr
2006;
19
: 450–456
(16581486).
26. Temporelli PL, Giannuzzi P, Nicolosi GL, Latini R, Franzosi MG,
Gentile F,
et al
. Doppler-derived mitral deceleration time as a strong
prognostic marker of left ventricular remodeling and survival after
acute myocardial infarction: results of the GISSI-3 echo substudy.
J Am
Coll Cardiol
2004;
43
: 1646–1653 (15120826).
